F. Deinhardt

428 total citations
28 papers, 288 citations indexed

About

F. Deinhardt is a scholar working on Epidemiology, Oncology and Immunology. According to data from OpenAlex, F. Deinhardt has authored 28 papers receiving a total of 288 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 6 papers in Oncology and 6 papers in Immunology. Recurrent topics in F. Deinhardt's work include Hepatitis B Virus Studies (5 papers), Virus-based gene therapy research (4 papers) and T-cell and Retrovirus Studies (4 papers). F. Deinhardt is often cited by papers focused on Hepatitis B Virus Studies (5 papers), Virus-based gene therapy research (4 papers) and T-cell and Retrovirus Studies (4 papers). F. Deinhardt collaborates with scholars based in Germany, United States and Switzerland. F. Deinhardt's co-authors include Hans Will, Heinz Schaller, Roberto Cattaneo, Huub Schellekens, G. Darai, William H. Knospe, J. E. Maynard, Gary R. Noble, K. von der Helm and F. Schödel and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Infectious Diseases and Vaccine.

In The Last Decade

F. Deinhardt

23 papers receiving 259 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
F. Deinhardt Germany	8	162	103	89	75	48	28	288
G Saimot France	8	270 1.7×	100 1.0×	48 0.5×	155 2.1×	37 0.8×	36	408
Mehrdad Ravanshad Iran	11	132 0.8×	116 1.1×	37 0.4×	106 1.4×	36 0.8×	52	352
Marion Gruffaz France	9	224 1.4×	49 0.5×	55 0.6×	152 2.0×	73 1.5×	11	316
Fengfeng Mao China	13	334 2.1×	176 1.7×	55 0.6×	163 2.2×	97 2.0×	19	487
Charles Harvey Australia	5	271 1.7×	76 0.7×	44 0.5×	343 4.6×	103 2.1×	6	467
Yukio Itoh Japan	10	268 1.7×	148 1.4×	20 0.2×	246 3.3×	23 0.5×	20	509
Sreedhar Chinnaswamy India	12	123 0.8×	113 1.1×	43 0.5×	177 2.4×	91 1.9×	25	370
Lisa R. Bishop United States	11	201 1.2×	134 1.3×	66 0.7×	7 0.1×	82 1.7×	17	376
Olivier Vidalin France	8	249 1.5×	53 0.5×	17 0.2×	306 4.1×	73 1.5×	8	413
André Edouard France	7	101 0.6×	19 0.2×	46 0.5×	74 1.0×	70 1.5×	15	249

Countries citing papers authored by F. Deinhardt

Since Specialization

Citations

This map shows the geographic impact of F. Deinhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Deinhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Deinhardt more than expected).

Fields of papers citing papers by F. Deinhardt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Deinhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Deinhardt. The network helps show where F. Deinhardt may publish in the future.

Co-authorship network of co-authors of F. Deinhardt

This figure shows the co-authorship network connecting the top 25 collaborators of F. Deinhardt. A scholar is included among the top collaborators of F. Deinhardt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Deinhardt. F. Deinhardt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Falk, L, Priscilla A. Schaffer, J. Michael Wright, et al.. (2015). Experimental Infection of Marmoset and Squirrel Monkeys with Attenuated HVS1. Proceedings of the International Symposium on Comparative Leukemia Research. 336–338.

Gürtler, Lutz, Josef Eberle, & F. Deinhardt. (2008). LAV/HTLV-III-Antikörper in Blut und Blutprodukten. DMW - Deutsche Medizinische Wochenschrift. 110(43). 1639–1640.

Hengster, Paul, F. Deinhardt, Volker Erfle, et al.. (2008). HTLV-III-Durchseuchung bei Personen mit intravenösem Drogenmißbrauch: Korrelation von Antikörpern gegen HTLV-III mit Neopterin und T_H/T_S. DMW - Deutsche Medizinische Wochenschrift. 111(12). 453–457.

Schätzl, Hermann, et al.. (1994). [A new variant of the simian T-lymphotropic retrovirus type I (STLV-IF) in the Sukhumi colony of hamadryas baboons].. PubMed. 38(6). 249–53. 2 indexed citations

Brunn, Albrecht von, et al.. (1993). Principal neutralizing domain of HIV-1 is highly immunogenic when expressed on the surface of hepatitis B core particles. Vaccine. 11(8). 817–824. 42 indexed citations

Schreier, E., Klaus Fuchs, Marina Höhne, et al.. (1992). Detection and characterization of hepatitis C virus sequence in the serum of a patient with chronic HCV infection. PubMed. 4. 179–183. 1 indexed citations

Zuckerman, Arie J. & F. Deinhardt. (1990). [Vaccines, cells and nucleic acids].. PubMed. 68(3). 293–5. 1 indexed citations

Gerok, W., et al.. (1990). Infectious diseases of the liver.. 11 indexed citations

Helm, K. von der, et al.. (1988). [Antibodies against HTLV I in T-lymphoproliferative diseases of the skin].. PubMed. 39(6). 348–50. 5 indexed citations

10.

Abb, Jochen, et al.. (1986). Circulating Interferon in Patients with Acute Hepatitis A. The Journal of Infectious Diseases. 153(6). 1174–1175. 8 indexed citations

11.

Will, Hans, Roberto Cattaneo, G. Darai, et al.. (1985). Infectious hepatitis B virus from cloned DNA of known nucleotide sequence.. Proceedings of the National Academy of Sciences. 82(3). 891–895. 70 indexed citations

12.

Hehlmann, Rüdiger, et al.. (1981). Fatal lymphoproliferation and acute monocytic leukemia-like disease following infectious mononucleosis in the elderly. Journal of Molecular Medicine. 59(10). 477–483. 2 indexed citations

13.

Wilmes, E., et al.. (1979). Die Bedeutung von Epstein-Barr-Virus-Antikörpern für Diagnose und Verlauf des Nasopharynxkarzinoms = Significance of virus-specific antibodies to EBV-antigens in patients with nasopharyngeal carcinoma (author's transl.). University of Regensburg Publication Server (University of Regensburg). 2 indexed citations

14.

Deinhardt, F.. (1978). Summary of research in primate oncogenic herpesviruses.. PubMed. 1087–8. 1 indexed citations

15.

Falk, L, Lauren G. Wolfe, & F. Deinhardt. (1975). Transformation in vitro with herpesvirus ateles.. PubMed. 379–84. 1 indexed citations

16.

Schäfer, Wolfram, G. Hunsmann, Robert L. Wollmann, et al.. (1974). [Evidence for the existence of different antigenic determinants of the interspecies type in mammalian RNA-C-type tumor viruses. Comparative serological studies on viruses of various animal species including a virus suggested to be of human origin (author's transl)].. PubMed. 28(3). 214–22. 1 indexed citations

17.

Mattenheimer, H., et al.. (1971). Enzymology of Experimental Liver Diseasein Marmoset Monkeys. Enzyme. 12(1). 99–116. 12 indexed citations

18.

Deinhardt, F., et al.. (1970). Development and Persistence of Immunity to Epstein-Barr Virus in Man. The Journal of Infectious Diseases. 122(5). 401–409. 69 indexed citations

19.

Deinhardt, F., et al.. (1969). IMMUNIZATION AGAINST MUMPS. The Medical Journal of Australia. 1(15). 774–776. 4 indexed citations

20.

Deinhardt, F.. (1968). Viral oncogenesis and results of inoculation of normal and transformed cells into nonhuman primates.. PubMed. 29. 327–31. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact